Kay Kwok Ng
Corporate Officer/Principal presso CPA Australia Ltd.
Posizioni attive di Kay Kwok Ng
Società | Posizione | Inizio | Fine |
---|---|---|---|
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Corporate Officer/Principal | 29/03/2010 | - |
Storia della carriera di Kay Kwok Ng
Precedenti posizioni note di Kay Kwok Ng
Società | Posizione | Inizio | Fine |
---|---|---|---|
CCIAM FUTURE ENERGY LIMITED | Direttore/Membro del Consiglio | 15/08/2018 | 01/09/2020 |
Independent Dir/Board Member | 15/08/2018 | 01/09/2020 | |
GOFINTECH INNOVATION LIMITED | Direttore/Membro del Consiglio | 14/09/2007 | 13/12/2019 |
Independent Dir/Board Member | 14/09/2007 | 13/12/2019 | |
NOIZ GROUP LIMITED | Direttore/Membro del Consiglio | 26/07/2013 | 01/04/2019 |
Independent Dir/Board Member | 26/07/2013 | 01/04/2019 | |
GET HOLDINGS LIMITED | Direttore/Membro del Consiglio | 01/01/2007 | 24/05/2013 |
Amministratore Delegato | 01/01/2007 | 24/05/2013 | |
Segretario Aziendale | 01/01/2007 | 31/05/2011 | |
Everpride Biopharmaceutical Co. Ltd.
Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Direttore/Membro del Consiglio | 08/04/2010 | 22/04/2010 |
Formazione di Kay Kwok Ng
Australian National University | Undergraduate Degree |
Macquarie University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Hong Kong | 6 |
Australia | 4 |
Posizioni
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Undergraduate Degree | 2 |
Settori
Finance | 3 |
Commercial Services | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
GOFINTECH INNOVATION LIMITED | Finance |
GET HOLDINGS LIMITED | Technology Services |
NOIZ GROUP LIMITED | Finance |
CCIAM FUTURE ENERGY LIMITED | Commercial Services |
Aziende private | 2 |
---|---|
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Commercial Services |
Everpride Biopharmaceutical Co. Ltd.
Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Health Technology |
- Borsa valori
- Insiders
- Kay Kwok Ng
- Esperienza